Correlation Between SHIN ETSU and XTANT MEDICAL

Can any of the company-specific risk be diversified away by investing in both SHIN ETSU and XTANT MEDICAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SHIN ETSU and XTANT MEDICAL into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SHIN ETSU CHEMICAL and XTANT MEDICAL HLDGS, you can compare the effects of market volatilities on SHIN ETSU and XTANT MEDICAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SHIN ETSU with a short position of XTANT MEDICAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of SHIN ETSU and XTANT MEDICAL.

Diversification Opportunities for SHIN ETSU and XTANT MEDICAL

0.81

Correlation Coefficient

SHIN ETSU  XTANT MEDICAL

Very poor diversification

The 3 months correlation between SHIN and XTANT is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding SHIN ETSU CHEMICAL and XTANT MEDICAL HLDGS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTANT MEDICAL HLDGS and SHIN ETSU is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SHIN ETSU CHEMICAL are associated (or correlated) with XTANT MEDICAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTANT MEDICAL HLDGS has no effect on the direction of SHIN ETSU i.e., SHIN ETSU and XTANT MEDICAL go up and down completely randomly.

Pair Corralation between SHIN ETSU and XTANT MEDICAL

Assuming the 90 days trading horizon SHIN ETSU CHEMICAL is expected to under-perform the XTANT MEDICAL. But the stock apears to be less risky and, when comparing its historical volatility, SHIN ETSU CHEMICAL is 1.2 times less risky than XTANT MEDICAL. The stock trades about -0.37 of its potential returns per unit of risk. The XTANT MEDICAL HLDGS is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest  36.00  in XTANT MEDICAL HLDGS on September 24, 2024 and sell it today you would lose (2.00) from holding XTANT MEDICAL HLDGS or give up 5.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

SHIN ETSU CHEMICAL  vs.  XTANT MEDICAL HLDGS

SHIN ETSU CHEMICAL

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SHIN ETSU CHEMICAL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

XTANT MEDICAL HLDGS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days XTANT MEDICAL HLDGS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with SHIN ETSU and XTANT MEDICAL

The main advantage of trading using opposite SHIN ETSU and XTANT MEDICAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SHIN ETSU position performs unexpectedly, XTANT MEDICAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTANT MEDICAL will offset losses from the drop in XTANT MEDICAL's long position.

The idea behind SHIN ETSU CHEMICAL and XTANT MEDICAL HLDGS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.